Federal officials are warning of a possible ADHD drug shortage after a subscription-based telehealth company was busted for fraud.
The Justice Department said the company sent 40 million pills to people who lacked legitimate prescriptions, and generated more than $100 million in revenue. The DOJ said He and Brody conspired to provide easy access to Adderall and other stimulants through a monthly subscription fee with Done.The Centers for Disease Control and Prevention said patients who rely on ADHD medication through Done or similar subscription-based telehealth platforms may experience a disruption to their treatment or access to care.